HomeIMVT • NASDAQ
add
Immunovant Inc
Previous close
$29.26
Day range
$29.10 - $29.71
Year range
$24.67 - $45.58
Market cap
4.31B USD
Avg Volume
995.70K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 94.28M | 42.90% |
Net income | -87.15M | -17.87% |
Net profit margin | — | — |
Earnings per share | -0.60 | -5.26% |
EBITDA | -94.20M | -42.89% |
Effective tax rate | -0.09% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 560.00M | 69.72% |
Total assets | 589.68M | 67.89% |
Total liabilities | 45.02M | -12.34% |
Total equity | 544.66M | — |
Shares outstanding | 146.37M | — |
Price to book | 7.84 | — |
Return on assets | -37.53% | — |
Return on capital | -40.55% | — |
Cash Flow
Net change in cash
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Net income | -87.15M | -17.87% |
Cash from operations | -76.20M | -60.86% |
Cash from investing | -182.00K | -304.44% |
Cash from financing | 686.00K | -22.92% |
Net change in cash | -75.36M | -61.81% |
Free cash flow | -47.73M | -229.64% |
About
Founded
2018
Website
Employees
207